Beyond Blood Pressure Numbers: When Blood Pressure Control Changes More Than the Heart

Objective: The authors present a 50-year-old male patient, smoker, without regular medical follow-up, with arterial hypertension since age 12 (without formal clinical diagnosis) and a family history of hypertension in his father, with no premature cardiovascular events. He was admitted to the Emergency Department after a BP of 247/121 mmHg documented during an outpatient visit. The patient was asymptomatic, without headache, visual disturbances, or precordial pain, but reported erectile dysfunction of several years’ duration. Laboratory evaluation showed normal renal function and mildly elevated high-sensitivity troponin T (20 ng/L; reference <13 ng/L). The electrocardiogram revealed sinus rhythm with criteria for left ventricular hypertrophy (LVH). The patient was discharged on antihypertensive therapy and referred to a hypertension outpatient clinic. Design and method: During follow-up, secondary causes of hypertension were excluded. Transthoracic echocardiography showed concentric LVH, with an interventricular septum of 13.5 mm, posterior wall 13.7 mm, and left ventricular mass 233.17 g (118.42 g/m2). Left ventricular systolic function was preserved, though global longitudinal strain was reduced (12.8%). Despite dual antihypertensive therapy, BP remained elevated (home SBP ∼180 mmHg, DBP 110–120 mmHg; in-office SBP >210 mmHg). Therapy was intensified to triple therapy with lifestyle counseling including CV risk factor control, smoking cessation, and dietary modification. Results: Over three years, BP gradually improved (SBP 120–135 mmHg, DBP 80–90 mmHg), coinciding with complete resolution of erectile dysfunction. Echocardiographic follow-up demonstrated regression of LVH: after one year, mild hypertrophy (septum 11.8 mm, posterior wall 10.8 mm, mass 159.07 g [80.79 g/m2]); after two years, mild hypertrophy persisted with meso-apical hypertrabeculation (septum 12.2 mm, posterior wall 11.9 mm, mass 172.8 g [87.98 g/m2]). Conclusions: Hypertension is associated with myocardial remodeling, particularly LVH, often clinically silent but it's a strong marker of CV risk. Adequate BP control can reverse hypertensive cardiac remodeling, reducing long-term CV risk. Additionally, hypertension causes erectile dysfunction, a symptomatic vascular manifestation impacting quality of life. This case highlights that effective BP control can simultaneously reverse asymptomatic target-organ damage and improve patient-centered outcomes.